Trial of Zileuton CR in Children and Adults With Sickle Cell Disease

NCT01136941 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Zileuton

Sponsor

Children's Hospital Medical Center, Cincinnati